Patient’s Barcodes

An article here suggests that six Trusts have been selected to introduce patient barcoding. Patients admitted to hospital will be issued with bracelets with barcodes. This is intended to reduce errors and increase efficiency.

There is also a nifty video explaining how this will work.


Network Analysis of Instagram data on medicines use

Research shows how data on social network (Instagram) have great potential for public health monitoring and surveillance for adverse drug reactions and drug-drug interactions.

Correia, Rion Brattig, Lang Li, and Luis M. Rocha. “Monitoring Potential Drug Interactions and Reactions via Network Analysis of Instagram User Timelines.” Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing. Vol. 21. NIH Public Access, 2016.

White House antibiotic summit and related initiatives

A blog on the summit on antibiotic resistance held by the White House on the 2nd of June 2015, with a summary of the day and links to resources about related White House initiatives and policies:

Today: Obama White House Convenes First Antibiotic Summit, by Maryn McKenna, on National Geographic:

News: Interpol raid on illegal medical drugs trade [in French]

From Le Monde:

Raid historique d’Interpol contre les pharmacies en ligne

‘D’après un rapport de la Commission européenne paru en 2012, les médicaments contrefaits sont ainsi les premiers produits saisis aux frontières de l’Union européenne via le trafic postal.
… Dans le monde, 6 % à 15 % du marché mondial de médicaments relève de la contrefaçon, selon l’Organisation mondiale […]

Fighting fake drugs with high-tech solutions

An article on how technology is used to counter medicines counterfeits, including
mPedigree – HP joint venture for drug authentication

and in closing:
“… academics, regulators and industry are rolling out new technologies to try and get a step ahead of the counterfeiters. But even the technologies’ inventors admit that nothing can replace a properly functioning national pharmaceutical regulatory […]

Pharma trade bodies and EU pharmacovigilance fees

News from Pharma Times, Feb 24 2014

Industry concern over EU pharmacovigilance fees

“The European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Generic medicines Association (EGA), the European biotech industry (EuropaBio), the Association of the European Self-Medication Industry (AESGP) and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) have issued a joint statement about their concerns for “the increasing […]

February 24th, 2014|Pharmacovigilance|0 Comments|